{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:17:53Z","timestamp":1794071873107,"version":"4.8.0"},"reference-count":354,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Italian Ministry of University and Research"},{"name":"FCT"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.diabres.2020.108233","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T20:14:42Z","timestamp":1591042482000},"page":"108233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":191,"special_numbering":"C","title":["Review of methods for detecting glycemic disorders"],"prefix":"10.1016","volume":"165","author":[{"given":"Michael","family":"Bergman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Abdul-Ghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph A.","family":"DeFronzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"Manco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Sesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Vanessa","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ceriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Cravalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Jagannathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Monnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Colette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"del Prato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana P.","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o S\u00e9rgio","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luiz","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paula","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rog\u00e9rio Tavares","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Filipe Raposo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Dorcely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouran","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Buysschaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2020.108233_b0005","series-title":"IDF Diabetes Atlas","author":"Federation","year":"2017"},{"key":"10.1016\/j.diabres.2020.108233_b0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S2213-8587(16)30321-7","article-title":"Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study","volume":"5","author":"Warren","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2020.108233_b0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S2213-8587(16)30328-X","article-title":"The need for international consensus on prediabetes","volume":"5","author":"Makaroff","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2020.108233_b0020","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1210\/jc.2018-02409","article-title":"When HbA1c and Blood Glucose Do Not Match: How Much Is Determined by Race, by Genetics, by Differences in Mean Red Blood Cell Age?","volume":"104","author":"Cohen","year":"2019","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.diabres.2020.108233_b0025","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1210\/er.2018-00284","article-title":"Potential Clinical Error Arising From Use of HbA1c in Diabetes: Effects of the Glycation Gap","volume":"40","author":"Nayak","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.diabres.2020.108233_b0030","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/db09-9028","article-title":"Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus","volume":"58","author":"Banting","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b0035","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2337\/diacare.24.12.2023","article-title":"Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control","volume":"24","author":"Bonora","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0040","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jclinepi.2005.01.019","article-title":"Diagnostic accuracy of glycohemoglobin A1c (HbA1c) for postprandial hyperglycemia was equivalent to that of fasting blood glucose","volume":"58","author":"Shibata","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.diabres.2020.108233_b0045","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2337\/diacare.21.8.1221","article-title":"Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects","volume":"21","author":"Ko","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0050","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2337\/diacare.25.2.275","article-title":"Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial","volume":"25","author":"Rohlfing","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0055","doi-asserted-by":"crossref","unstructured":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183\u201397.","DOI":"10.2337\/diacare.20.7.1183"},{"key":"10.1016\/j.diabres.2020.108233_b0060","doi-asserted-by":"crossref","unstructured":"Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes. 1979;28:1039\u201357.","DOI":"10.2337\/diab.28.12.1039"},{"key":"10.1016\/j.diabres.2020.108233_b0065","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/bmj.308.6940.1323","article-title":"Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes","volume":"308","author":"McCance","year":"1994","journal-title":"BMJ (Clin Res Ed)"},{"key":"10.1016\/j.diabres.2020.108233_b0070","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2337\/diacare.20.5.785","article-title":"Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes Diagnostic criteria and performance revisited","volume":"20","author":"Engelgau","year":"1997","journal-title":"Diabetes care"},{"key":"10.1016\/j.diabres.2020.108233_b0075","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF01223157","article-title":"Fasting and two-hour post-load glucose levels for the diagnosis of diabetes. The relationship between glucose levels and complications of diabetes in the Pima Indians","volume":"16","author":"Rushforth","year":"1979","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108233_b0080","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0168-8227(00)00156-X","article-title":"Importance of OGTT for diagnosing diabetes mellitus based on prevalence and incidence of retinopathy","volume":"49","author":"Ito","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2020.108233_b0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.diabres.2006.02.008","article-title":"Diagnostic thresholds for diabetes: the association of retinopathy and albuminuria with glycaemia","volume":"73","author":"Tapp","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2020.108233_b0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1475-2840-13-45","article-title":"Thresholds of various glycemic measures for diagnosing diabetes based on prevalence of retinopathy in community-dwelling Japanese subjects: the Hisayama Study","volume":"13","author":"Mukai","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2020.108233_b0095","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2337\/dc17-1900","article-title":"One-Hour Plasma Glucose Compared With Two-Hour Plasma Glucose in Relation to Diabetic Retinopathy in American Indians","volume":"41","author":"Paddock","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2337\/dc10-1206","article-title":"Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes","volume":"34","author":"Colagiuri","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0105","doi-asserted-by":"crossref","first-page":"034","DOI":"10.17352\/ijcem.000027","article-title":"Diabetic Retinopathy: Focus on Minority Populations","volume":"3","author":"Barsegian","year":"2017","journal-title":"Int J Clin Endocrinol Metabol"},{"key":"10.1016\/j.diabres.2020.108233_b0110","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/1479164117739316","article-title":"Diabetes based on 2-h plasma glucose among those classified as having prediabetes based on fasting plasma glucose or A1c","volume":"15","author":"Menke","year":"2018","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/j.diabres.2020.108233_b0115","doi-asserted-by":"crossref","unstructured":"Gillett MJ. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes: Diabetes Care 2009; 32(7): 1327\u201334. The Clinical biochemist Reviews. 2009;30:197\u2013200.","DOI":"10.2337\/dc09-9033"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2020.108233_b0120","first-page":"S62","volume":"33","author":"Diagnosis and classification of diabetes mellitus","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0125","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1515\/CCLM.2003.184","article-title":"Haemoglobin A1c: analysis and standardisation","volume":"41","author":"John","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.diabres.2020.108233_b0130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.diabres.2009.12.013","article-title":"Effect of age and race\/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes","volume":"87","author":"Davidson","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2020.108233_b0135","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1089\/met.2013.0128","article-title":"Use of HbA1c for diagnoses of diabetes and prediabetes: comparison with diagnoses based on fasting and 2-hr glucose values and effects of gender, race, and age","volume":"12","author":"Guo","year":"2014","journal-title":"Metabolic Syndrome Related Disorders"},{"key":"10.1016\/j.diabres.2020.108233_b0140","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1210\/jc.2010-1171","article-title":"Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c","volume":"95","author":"Lipska","year":"2010","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.diabres.2020.108233_b0145","first-page":"51","article-title":"Are the ADA hemoglobin A(1c) criteria relevant for the diagnosis of type 2 diabetes in youth?","volume":"13","author":"Kapadia","year":"2013","journal-title":"Curr DiabRep"},{"key":"10.1016\/j.diabres.2020.108233_b0150","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.pedneo.2018.11.002","article-title":"Comparison of HbA1c and OGTT for the diagnosis of type 2 diabetes in children at risk of diabetes","volume":"60","author":"Kim","year":"2019","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.diabres.2020.108233_b0155","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.2337\/dc08-0577","article-title":"Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001\u20132004","volume":"31","author":"Pani","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0160","doi-asserted-by":"crossref","unstructured":"Booth RA, Jiang Y, Morrison H, Orpana H, Rogers Van Katwyk S, Lemieux C. Ethnic dependent differences in diagnostic accuracy of glycated hemoglobin (HbA1c) in Canadian adults. Diabetes research and clinical practice. 2018;136:143\u20139.","DOI":"10.1016\/j.diabres.2017.11.035"},{"key":"10.1016\/j.diabres.2020.108233_b0165","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2337\/dc06-2003","article-title":"Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program","volume":"30","author":"Herman","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0170","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/0003-4819-157-3-201208070-00004","article-title":"Should the hemoglobin A1c diagnostic cutoff differ between blacks and whites? A cross-sectional study","volume":"157","author":"Tsugawa","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2020.108233_b0175","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.2337\/dc05-1973","article-title":"Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis","volume":"29","author":"Kirk","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0180","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2337\/dc09-1843","article-title":"Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups","volume":"33","author":"Christensen","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0185","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/diacare.23.2.187","article-title":"Use of GHb (HbA1c) in screening for undiagnosed diabetes in the US population","volume":"23","author":"Rohlfing","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0190","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.2337\/dc10-0958","article-title":"A1C and diabetes diagnosis among Filipino Americans, Japanese Americans, and Native Hawaiians","volume":"33","author":"Araneta","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002383","article-title":"Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis","volume":"14","author":"Wheeler","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.diabres.2020.108233_b0200","first-page":"52","article-title":"Impact of Genetic Determinants of HbA1c on Type 2 Diabetes Risk and Diagnosis","volume":"18","author":"Sarnowski","year":"2018","journal-title":"Curr DiabRep"},{"key":"10.1016\/j.diabres.2020.108233_b0205","doi-asserted-by":"crossref","DOI":"10.2337\/dc19-0168","article-title":"A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics\/Latinos","author":"Moon","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0210","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/dc16-0042","article-title":"Are There Clinical Implications of Racial Differences in HbA1c? A Difference, to Be a Difference, Must Make a Difference","volume":"39","author":"Selvin","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0215","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2337\/dc15-2686","article-title":"Are There Clinical Implications of Racial Differences in HbA1c? Yes, to Not Consider Can Do Great Harm!","volume":"39","author":"Herman","year":"2016","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"10.1016\/j.diabres.2020.108233_b0220","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.2337\/dc11-s216","article-title":"The pros and cons of diagnosing diabetes with A1C","volume":"34","author":"Bonora","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0225","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.2337\/dc10-0433","article-title":"Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria","volume":"33","author":"Olson","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0230","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.2337\/dc11-0329","article-title":"Hemoglobin A1c, fasting glucose, and cardiovascular risk in a population with high prevalence of diabetes: the strong heart study","volume":"34","author":"Wang","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0235","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1464-5491.2007.02106.x","article-title":"HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review","volume":"24","author":"Bennett","year":"2007","journal-title":"Diabetic Med: J British Diabetic Assoc"},{"key":"10.1016\/j.diabres.2020.108233_b0240","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1111\/dme.12088","article-title":"HbA(1c) as a diagnostic tool for diabetes and pre-diabetes: the Bangladesh experience","volume":"30","author":"Bhowmik","year":"2013","journal-title":"Diabetic Med: J British Diabetic Assoc"},{"key":"10.1016\/j.diabres.2020.108233_b0245","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pcd.2011.02.002","article-title":"HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians","volume":"5","author":"Nair","year":"2011","journal-title":"Primary Care Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b0250","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"New Engl J Med"},{"key":"10.1016\/j.diabres.2020.108233_b0255","unstructured":"Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants. Lancet Diabetes Endocrinol. 2015;3:624\u201337."},{"key":"10.1016\/j.diabres.2020.108233_b0260","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2337\/dc09-1410","article-title":"Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao","volume":"33","author":"Zhou","year":"2010","journal-title":"China Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0265","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/1753-0407.12305","article-title":"Plasma glucose and hemoglobin A1c for the detection of diabetes in Chinese adults","volume":"8","author":"Xu","year":"2016","journal-title":"J Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b0270","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.diabres.2019.05.026","article-title":"Isolated HbA1c identifies a different subgroup of individuals with type 2 diabetes compared to fasting or post-challenge glucose in Asian Indians: The CARRS and MASALA studies","volume":"153","author":"Gujral","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2020.108233_b0275","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2337\/dc14-1179","article-title":"Detection of abnormal glucose tolerance in Africans is improved by combining A1C with fasting glucose: the Africans in America Study","volume":"38","author":"Sumner","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0280","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2337\/dc09-1227","article-title":"Comparison of A1C and fasting glucose criteria to diagnose diabetes among US adults","volume":"33","author":"Carson","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0285","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.2337\/diacare.21.8.1236","article-title":"Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men","volume":"21","author":"Barrett-Connor","year":"1998","journal-title":"Rancho Bernardo Study Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0290","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2337\/dc05-2179","article-title":"Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose","volume":"29","author":"Abdul-Ghani","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0295","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.1464-5491.2002.00835.x","article-title":"Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention","volume":"19","author":"Unwin","year":"2002","journal-title":"Diabetic Med: J British Diabetic Assoc"},{"key":"10.1016\/j.diabres.2020.108233_b0300","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"Follow-up report on the diagnosis of diabetes mellitus","volume":"26","author":"Genuth","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0305","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2337\/db05-1200","article-title":"Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study","volume":"55","author":"Abdul-Ghani","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b0310","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2796.2004.01336.x","article-title":"High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius","volume":"256","author":"Soderberg","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.diabres.2020.108233_b0315","doi-asserted-by":"crossref","first-page":"3b","DOI":"10.1016\/j.amjcard.2011.03.013","article-title":"Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose","volume":"108","author":"DeFronzo","year":"2011","journal-title":"Am J Cardiol"},{"issue":"681\u20135","key":"10.1016\/j.diabres.2020.108233_b0320","article-title":"Contributions of A1c, fasting plasma glucose, and 2-hour plasma glucose to prediabetes prevalence: NHANES 2011\u20132014","volume":"28","author":"Menke","year":"2018","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.diabres.2020.108233_b0325","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(11)60472-8","article-title":"HbA1c 5.7-6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study","volume":"378","author":"Heianza","year":"2011","journal-title":"Lancet (Lond, Engl)"},{"key":"10.1016\/j.diabres.2020.108233_b0330","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2337\/dc10-1352","article-title":"The relationship between {beta}-cell function and glycated hemoglobin: results from the veterans administration genetic epidemiology study","volume":"34","author":"Kanat","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0335","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1210\/jc.2018-00468","article-title":"One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes","volume":"103","author":"Fiorentino","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2020.108233_b0340","doi-asserted-by":"crossref","unstructured":"Bergman M, Manco M, Sesti G, Dankner R, Pareek M, Jagannathan R, et al. Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose>\/=155mg\/dl (8.6mmol\/L). Diabetes research and clinical practice. 2018;146:18\u201333.","DOI":"10.1016\/j.diabres.2018.09.017"},{"key":"10.1016\/j.diabres.2020.108233_b0345","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2337\/dc08-0225","article-title":"One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes","volume":"31","author":"Abdul-Ghani","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0350","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00125-014-3390-x","article-title":"Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts","volume":"58","author":"Alyass","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108233_b0355","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jc.2010-1698","article-title":"Role of glycated hemoglobin in the prediction of future risk of T2DM","volume":"96","author":"Abdul-Ghani","year":"2011","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.diabres.2020.108233_b0360","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/dme.12994","article-title":"One-hour plasma glucose as a predictor of the development of Type 2 diabetes in Japanese adults","volume":"33","author":"Oka","year":"2016","journal-title":"Diabetic Med: J British Diabetic Assoc"},{"key":"10.1016\/j.diabres.2020.108233_b0365","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/jdi.12353","article-title":"Predictability of 1-h postload plasma glucose concentration: A 10-year retrospective cohort study","volume":"6","author":"Kuang","year":"2015","journal-title":"J Diabetes Invest"},{"key":"10.1016\/j.diabres.2020.108233_b0370","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/cen.13280","article-title":"One-hour postload plasma glucose concentration in people with normal glucose homeostasis predicts future diabetes mellitus: a 12-year community-based cohort study","volume":"86","author":"Oh","year":"2017","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.diabres.2020.108233_b0375","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1007\/s00125-017-4332-1","article-title":"One-hour and two-hour postload plasma glucose concentrations are comparable predictors of type 2 diabetes mellitus in Southwestern Native Americans","volume":"60","author":"Paddock","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108233_b0380","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.jdiacomp.2017.07.017","article-title":"The 1h post glucose value best predicts future dysglycemia among normal glucose tolerance subjects","volume":"31","author":"Sai Prasanna","year":"2017","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.diabres.2020.108233_b0385","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1210\/jc.2018-01828","article-title":"1-Hour Post-OGTT Glucose Improves the Early Prediction of Type 2 Diabetes by Clinical and Metabolic Markers","volume":"104","author":"Peddinti","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2020.108233_b0390","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2337\/dc08-1264","article-title":"Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study","volume":"32","author":"Abdul-Ghani","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0395","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.diabres.2016.08.013","article-title":"One-hour post-load plasma glucose level during the OGTT predicts dysglycemia: Observations from the 24year follow-up of the Israel Study of Glucose Intolerance, Obesity and Hypertension","volume":"120","author":"Bergman","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2020.108233_b0400","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/dia.2013.0025","article-title":"1-hour venous plasma glucose and incident prediabetes and diabetes in Asian indians","volume":"15","author":"Priya","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2020.108233_b0405","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1210\/jc.2015-2573","article-title":"One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose","volume":"100","author":"Fiorentino","year":"2015","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.diabres.2020.108233_b0410","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2337\/dc17-1351","article-title":"Enhanced Predictive Capability of a 1-Hour Oral Glucose Tolerance Test: A Prospective Population-Based Cohort Study","volume":"41","author":"Pareek","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0415","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00125-018-4798-5","article-title":"One hour post-load plasma glucose and 3 year risk of worsening fasting and 2 hour glucose tolerance in the RISC cohort","volume":"62","author":"Manco","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108233_b0420","doi-asserted-by":"crossref","first-page":"868","DOI":"10.2337\/dc11-2181","article-title":"Insulin sensitivity, beta-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels","volume":"35","author":"Marini","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0425","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2012-3971","article-title":"Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired beta-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study","volume":"98","author":"Bianchi","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2020.108233_b0430","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12020-015-0746-z","article-title":"Elevated 1-hour plasma glucose levels are associated with dysglycemia, impaired beta-cell function, and insulin sensitivity: a pilot study from a real world health care setting","volume":"52","author":"Jagannathan","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.diabres.2020.108233_b0435","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.2337\/dc09-2261","article-title":"One-hour plasma glucose identifies insulin resistance and beta-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study","volume":"33","author":"Manco","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0440","first-page":"572","article-title":"One-hour plasma glucose concentration during the OGTT: what does it tell about beta-cell function relative to insulin sensitivity in overweight\/obese children?","volume":"12","author":"Tfayli","year":"2011","journal-title":"Pediatric Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b0445","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2337\/dc12-1861","article-title":"One-hour glucose during an oral glucose challenge prospectively predicts beta-cell deterioration and prediabetes in obese Hispanic youth","volume":"36","author":"Kim","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0450","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40618-017-0638-6","article-title":"One-hour post-load plasma glucose levels associated with decreased insulin sensitivity and secretion and early makers of cardiometabolic risk","volume":"40","author":"Marcovecchio","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.diabres.2020.108233_b0455","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/cen.13859","article-title":"Elevated 1-hour post-load plasma glucose identifies obese youth with abnormal glucose metabolism and an unfavourable inflammatory profile","volume":"89","author":"Serbis","year":"2018","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.diabres.2020.108233_b0460","first-page":"608","article-title":"Insulin degradation: progress and potential","volume":"19","author":"Duckworth","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.diabres.2020.108233_b0465","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2337\/dc12-1316","article-title":"Insulin clearance and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS Family Study","volume":"36","author":"Lee","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077440","article-title":"Decreased insulin clearance in individuals with elevated 1-h post-load plasma glucose levels","volume":"8","author":"Marini","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2020.108233_b0475","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1113\/jphysiol.1988.sp017015","article-title":"Nutrient uptake by rat enterocytes during diabetes mellitus; evidence for an increased sodium electrochemical gradient","volume":"397","author":"Debnam","year":"1988","journal-title":"J Physiol"},{"key":"10.1016\/j.diabres.2020.108233_b0480","doi-asserted-by":"crossref","first-page":"C601","DOI":"10.1152\/ajpcell.00135.2009","article-title":"Diabetes mellitus and expression of the enterocyte renin-angiotensin system: implications for control of glucose transport across the brush border membrane","volume":"297","author":"Wong","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.diabres.2020.108233_b0485","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1172\/JCI117010","article-title":"Small intestine hexose transport in experimental diabetes. Increased transporter mRNA and protein expression in enterocytes","volume":"93","author":"Burant","year":"1994","journal-title":"J Clin Investig"},{"key":"10.1016\/j.diabres.2020.108233_b0490","doi-asserted-by":"crossref","first-page":"G241","DOI":"10.1152\/ajpgi.00310.2001","article-title":"Expression of monosaccharide transporters in intestine of diabetic humans","volume":"282","author":"Dyer","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.diabres.2020.108233_b0495","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1210\/JC.2015-2482","article-title":"Relationships of Early And Late Glycemic Responses With Gastric Emptying During An Oral Glucose Tolerance Test","volume":"100","author":"Marathe","year":"2015","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.diabres.2020.108233_b0500","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1210\/jc.2017-00348","article-title":"Duodenal Sodium\/Glucose Cotransporter 1 Expression Under Fasting Conditions Is Associated With Postload Hyperglycemia","volume":"102","author":"Fiorentino","year":"2017","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.diabres.2020.108233_b0505","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1210\/jc.2018-02166","article-title":"Intestinal Glucose Absorption Is a Key Determinant of 1-Hour Postload Plasma Glucose Levels in Nondiabetic Subjects","volume":"104","author":"Trico","year":"2019","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.diabres.2020.108233_b0510","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/db11-1029","article-title":"Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion","volume":"61","author":"Gorboulev","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b0515","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.nutr.28.061807.155518","article-title":"Sugar absorption in the intestine: the role of GLUT2","volume":"28","author":"Kellett","year":"2008","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.diabres.2020.108233_b0520","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3315","article-title":"The contribution of unrecognized factors to the diabetes epidemic","author":"Bergman","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabres.2020.108233_b0525","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0895-4356(97)00201-1","article-title":"One-hour postload plasma glucose and risks of fatal coronary heart disease and stroke among nondiabetic men and women: the Chicago Heart Association Detection Project in Industry (CHA) Study","volume":"50","author":"Orencia","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.diabres.2020.108233_b0530","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.2337\/diacare.15.10.1328","article-title":"Relationship of postload plasma glucose to mortality with 19-yr follow-up. Comparison of one versus two plasma glucose measurements in the Chicago Peoples Gas","volume":"15","author":"Vaccaro","year":"1992","journal-title":"Company Study Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0535","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinternmed.2011.183","article-title":"One-hour glucose, mortality, and risk of diabetes: a 44-year prospective study in men","volume":"171","author":"Strandberg","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diabres.2020.108233_b0540","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/dia.2017.0135","article-title":"Targeting One-Hour Postmeal Glucose: Is It Time for a Paradigm Switch in Diabetes Management?","volume":"19","author":"Ceriello","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2020.108233_b0545","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2016.08.020","article-title":"One-hour post-load hyperglycemia combined with HbA1c identifies pre-diabetic individuals with a higher cardio-metabolic risk burden","volume":"253","author":"Fiorentino","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.diabres.2020.108233_b0550","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000837","article-title":"Metabolic characteristics of Africans with normal glucose tolerance and elevated 1-hour glucose: insight from the Africans in America study","volume":"8","author":"Briker","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.diabres.2020.108233_b0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030374","article-title":"Combining information from common type 2 diabetes risk polymorphisms improves disease prediction","volume":"3","author":"Weedon","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.diabres.2020.108233_b0560","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/s41588-018-0241-6","article-title":"Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps","volume":"50","author":"Mahajan","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.diabres.2020.108233_b0565","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.diabres.2020.108233_b0570","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1017\/thg.2015.83","article-title":"The Concordance and Heritability of Type 2 Diabetes in 34,166 Twin Pairs From International Twin Registers: The Discordant Twin (DISCOTWIN) Consortium","volume":"18","author":"Willemsen","year":"2015","journal-title":"Twin Res Hum Genet: Off J Int Soc Twin Stud"},{"key":"10.1016\/j.diabres.2020.108233_b0575","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1210\/er.2019-00088","article-title":"Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine","volume":"40","author":"Udler","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.diabres.2020.108233_b0580","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1056\/NEJMoa0804742","article-title":"Genotype score in addition to common risk factors for prediction of type 2 diabetes","volume":"359","author":"Meigs","year":"2008","journal-title":"New Engl J Med"},{"key":"10.1016\/j.diabres.2020.108233_b0585","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.2337\/db08-0504","article-title":"Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk","volume":"57","author":"Lango","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b0590","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa0801869","article-title":"Clinical risk factors, DNA variants, and the development of type 2 diabetes","volume":"359","author":"Lyssenko","year":"2008","journal-title":"New Engl J Med"},{"key":"10.1016\/j.diabres.2020.108233_b0595","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.2337\/db13-1663","article-title":"Polygenic type 2 diabetes prediction at the limit of common variant detection","volume":"63","author":"Vassy","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b0600","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng.609","article-title":"Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis","volume":"42","author":"Voight","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.diabres.2020.108233_b0605","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.2337\/db13-0949","article-title":"Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity","volume":"63","author":"Dimas","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b0610","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.2337\/db14-0319","article-title":"Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity","volume":"63","author":"Scott","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b0615","article-title":"Human Genetics of Obesity and Type 2 Diabetes Mellitus: Past, Present, and Future","volume":"11","author":"Ingelsson","year":"2018","journal-title":"Circul Genomic Precision Med"},{"key":"10.1016\/j.diabres.2020.108233_b0620","doi-asserted-by":"crossref","first-page":"538","DOI":"10.2337\/diab.24.6.538","article-title":"Comparison of the value of the two- and one-hour glucose levels of the oral GTT in the diagnosis of diabetes in Pima Indians","volume":"24","author":"Rushforth","year":"1975","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b0625","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc19-S002","article-title":"Standards of Medical Care in Diabetes-2019","volume":"42","author":"Classification and Diagnosis of Diabetes","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0630","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0002-9378(82)90349-0","article-title":"Criteria for screening tests for gestational diabetes","volume":"144","author":"Carpenter","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.diabres.2020.108233_b0635","doi-asserted-by":"crossref","unstructured":"International Association of D, Pregnancy Study Groups Consensus P, Metzger BE, Gabbe SG, Persson B, Buchanan TA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes care. 2010;33:676\u201382.","DOI":"10.2337\/dc09-1848"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2020.108233_b0640","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc11-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"34","author":"American Diabetes Association","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0645","doi-asserted-by":"crossref","unstructured":"Committee on Practice B-O. ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol. 2018;131:e49\u2013e64.","DOI":"10.1097\/AOG.0000000000002501"},{"key":"10.1016\/j.diabres.2020.108233_b0650","first-page":"7","article-title":"WHO Criteria by Combining the Glucose Challenge Test and Clinical Risk Factors","volume":"2018","author":"Benhalima","year":"2013","journal-title":"J Clin Med"},{"key":"10.1016\/j.diabres.2020.108233_b0655","article-title":"Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis","volume":"354","author":"Farrar","year":"2016","journal-title":"BMJ (Clin Res Ed)"},{"key":"10.1016\/j.diabres.2020.108233_b0660","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2337\/dc07-1957","article-title":"Modestly elevated glucose levels during pregnancy are associated with a higher risk of future diabetes among women without gestational diabetes mellitus","volume":"31","author":"Carr","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0665","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(09)60731-5","article-title":"Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis","volume":"373","author":"Bellamy","year":"2009","journal-title":"Lancet (Lond, Engl)"},{"key":"10.1016\/j.diabres.2020.108233_b0670","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/obr.12645","article-title":"Long-term risk of diabetes in women at varying durations after gestational diabetes: a systematic review and meta-analysis with more than 2 million women","volume":"19","author":"Song","year":"2018","journal-title":"Obesity Rev: Off J Int Assoc Study Obesity"},{"key":"10.1016\/j.diabres.2020.108233_b0675","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.2337\/dc14-1529","article-title":"Each degree of glucose intolerance in pregnancy predicts distinct trajectories of beta-cell function, insulin sensitivity, and glycemia in the first 3 years postpartum","volume":"37","author":"Kramer","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0680","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/jama.2018.11628","article-title":"Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity","volume":"320","author":"Lowe","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2020.108233_b0685","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00125-019-4840-2","article-title":"Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis","volume":"62","author":"Kramer","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108233_b0690","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1055\/s-0037-1604193","article-title":"High-Normal Glucose Levels in a Routine Oral 1-Hour 50 g Glucose Challenge Test Are Associated with a Poorer Glycemic Status Later in Life","volume":"34","author":"Yoles","year":"2017","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.diabres.2020.108233_b0695","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1464-5491.2009.02712.x","article-title":"Abnormal screening glucose challenge test in pregnancy and future risk of diabetes in young women","volume":"26","author":"Retnakaran","year":"2009","journal-title":"Diabetic Med: J British Diabetic Assoc"},{"key":"10.1016\/j.diabres.2020.108233_b0700","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1007\/s00125-009-1407-7","article-title":"Glucose challenge test screening for prediabetes and undiagnosed diabetes","volume":"52","author":"Phillips","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108233_b0705","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/dme.13270","article-title":"Glucose challenge test screening for prediabetes and early diabetes","volume":"34","author":"Jackson","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2020.108233_b0710","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2337\/dc06-1331","article-title":"What is the best predictor of future type 2 diabetes?","volume":"30","author":"Abdul-Ghani","year":"2007","journal-title":"Diab Care"},{"key":"10.1016\/j.diabres.2020.108233_b0715","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.2337\/dc12-1752","article-title":"Screening for diabetes and prediabetes should be cost-saving in patients at high risk","volume":"36","author":"Chatterjee","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0720","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.2337\/diacare.21.10.1686","article-title":"The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study","volume":"21","author":"de Vegt","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0725","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000464144","article-title":"Inside out the Ragbag of Glucose Intolerance in Obese Adolescents","volume":"87","author":"Brufani","year":"2017","journal-title":"Hormone Res Paediatr"},{"key":"10.1016\/j.diabres.2020.108233_b0730","doi-asserted-by":"crossref","unstructured":"Yin C, Zhang H, Xiao Y, Liu W. Shape of glucose curve can be used as a predictor for screening prediabetes in obese children. Acta paediatrica (Oslo, Norway: 1992). 2014;103:e199\u2013205.","DOI":"10.1111\/apa.12572"},{"key":"10.1016\/j.diabres.2020.108233_b0735","doi-asserted-by":"crossref","first-page":"R941","DOI":"10.1152\/ajpregu.00650.2010","article-title":"Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance?","volume":"300","author":"Tura","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.diabres.2020.108233_b0740","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/diacare.26.4.1026","article-title":"Assessing the shape of the glucose curve during an oral glucose tolerance test","volume":"26","author":"Tschritter","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0745","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/EJE-11-0827","article-title":"Beyond the morphology of the glucose curve following an oral glucose tolerance test in obese youth","volume":"166","author":"Nolfe","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.diabres.2020.108233_b0750","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2337\/diab.2.4.299","article-title":"A new technic for the detection of hidden diabetes: induction of hyperglycemia by feeding glucose after dietary preparation","volume":"2","author":"Engelhardt","year":"1953","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b0755","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.2337\/dc18-0279","article-title":"Pathophysiological Characteristics Underlying Different Glucose Response Curves: A Latent Class Trajectory Analysis From the Prospective EGIR-RISC Study","volume":"41","author":"Hulman","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0760","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2337\/dc16-0352","article-title":"The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth","volume":"39","author":"Kim","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0765","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.2337\/dc11-2476","article-title":"Glucose response curve and type 2 diabetes risk in Latino adolescents","volume":"35","author":"Kim","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0770","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1368-5031.2005.00422.x","article-title":"Beta-cell function and insulin sensitivity contribute to the shape of plasma glucose curve during an oral glucose tolerance test in non-diabetic individuals","volume":"59","author":"Kanauchi","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.diabres.2020.108233_b0775","first-page":"445","article-title":"The shape of the plasma glucose curve during an oral glucose tolerance test as an indicator of Beta cell function and insulin sensitivity in end-pubertal obese girls","volume":"47","author":"Bervoets","year":"2015","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.diabres.2020.108233_b0780","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/cen.13416","article-title":"Time to glucose peak during an oral glucose tolerance test identifies prediabetes risk","volume":"87","author":"Chung","year":"2017","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.diabres.2020.108233_b0785","doi-asserted-by":"crossref","unstructured":"Manco M, Nolfe G, Pataky Z, Monti L, Porcellati F, Gabriel R, et al. Shape of the OGTT glucose curve and risk of impaired glucose metabolism in the EGIR-RISC cohort. Metabolism: clinical and experimental. 2017;70:42\u201350.","DOI":"10.1016\/j.metabol.2017.02.007"},{"key":"10.1016\/j.diabres.2020.108233_b0790","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00125-017-4453-6","article-title":"The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes","volume":"61","author":"Ismail","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108233_b0795","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/dmrr.1084","article-title":"The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes","volume":"26","author":"Abdul-Ghani","year":"2010","journal-title":"Diabetes\/metabol Res Rev"},{"key":"10.1016\/j.diabres.2020.108233_b0800","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2288-13-6","article-title":"Shape information from glucose curves: functional data analysis compared with traditional summary measures","volume":"13","author":"Froslie","year":"2013","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.diabres.2020.108233_b0805","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2337\/dc18-1122","article-title":"The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test: Forerunner of Heightened Glycemic Failure Rates and Accelerated Decline in beta-Cell Function in TODAY","volume":"42","author":"Arslanian","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0810","doi-asserted-by":"crossref","unstructured":"Cree-Green M, Xie D, Rahat H, Garcia-Reyes Y, Bergman BC, Scherzinger A, et al. Oral glucose tolerance test glucose peak time is most predictive of pre-diabetes and hepatic steatosis in obese girls. J Endocrine Soc. 2018:js.2018-00041-js.2018-.","DOI":"10.1210\/js.2018-00041"},{"key":"10.1016\/j.diabres.2020.108233_b0815","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/pedi.12803","article-title":"Two- vs one-hour glucose tolerance testing: Predicting prediabetes in adolescent girls with obesity","volume":"20","author":"Kasturi","year":"2019","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b0820","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.diabet.2016.12.005","article-title":"Reproducibility and least significant differences of oral glucose tolerance test-derived parameters in a postmenopausal population without diabetes","volume":"43","author":"Van de Velde","year":"2017","journal-title":"Diabetes Metabol"},{"key":"10.1016\/j.diabres.2020.108233_b0825","first-page":"1145","article-title":"A self-organizing map based morphological analysis of oral glucose tolerance test curves in women with gestational diabetes mellitus","volume":"160","author":"Gaetano","year":"2010","journal-title":"Stud Health Technol Inform"},{"issue":"1","key":"10.1016\/j.diabres.2020.108233_b0830","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00125-014-3390-x","article-title":"Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts","volume":"58","author":"Alyass","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108233_b0835","doi-asserted-by":"crossref","unstructured":"Hulman A, Simmons RK, Vistisen D, Tabak AG, Dekker JM, Alssema M, et al. Heterogeneity in glucose response curves during an oral glucose tolerance test and associated cardiometabolic risk. Endocrine. 2017;55:427\u201334.","DOI":"10.1007\/s12020-016-1126-z"},{"key":"10.1016\/j.diabres.2020.108233_b0840","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00125-017-4468-z","article-title":"Glucose patterns during an oral glucose tolerance test and associations with future diabetes, cardiovascular disease and all-cause mortality rate","volume":"61","author":"Hulman","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108233_b0845","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.diabres.2017.01.009","article-title":"Glucose patterns during the OGTT and risk of future diabetes in an urban Indian population: The CARRS study","volume":"126","author":"Hulman","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2020.108233_b0850","doi-asserted-by":"crossref","DOI":"10.2337\/dc18-2397","article-title":"Glucose Measurements at Various Time Points During the OGTT and Their Role in Capturing Glucose Response Patterns","author":"Hulman","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0855","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2337\/dci17-0043","article-title":"Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group","volume":"40","author":"Petrie","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0860","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/dc17-1600","article-title":"International Consensus on Use of Continuous Glucose Monitoring","volume":"40","author":"Danne","year":"2017","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"10.1016\/j.diabres.2020.108233_b0865","first-page":"S3","article-title":"Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities","volume":"18","author":"Rodbard","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2020.108233_b0870","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1089\/dia.2017.0025","article-title":"Factory-Calibrated Continuous Glucose Sensors: The Science Behind the Technology","volume":"19","author":"Hoss","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2020.108233_b0875","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/1932296814528134","article-title":"Self-monitoring of blood glucose: a prerequisite for diabetes management in outcome trials","volume":"8","author":"Schnell","year":"2014","journal-title":"J Diabetes Sci Technol"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2020.108233_b0880","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1089\/dia.2015.1501","article-title":"Self-monitoring of blood glucose","volume":"17","author":"Garg","year":"2015","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2020.108233_b0885","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1089\/dia.2018.0092","article-title":"Glucose Variability: A Review of Clinical Applications and Research Developments","volume":"20","author":"Rodbard","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2020.108233_b0890","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(18)30136-0","article-title":"Glycaemic variability in diabetes: clinical and therapeutic implications","volume":"7","author":"Ceriello","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2020.108233_b0895","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.diabet.2018.02.008","article-title":"The application of simple metrics in the assessment of glycaemic variability","volume":"44","author":"Monnier","year":"2018","journal-title":"Diabetes & metabolism"},{"key":"10.1016\/j.diabres.2020.108233_b0900","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1089\/dia.2017.0024","article-title":"Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes","volume":"19","author":"Carlson","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2020.108233_b0905","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2018-02763","article-title":"Continuous Glucose Monitoring Profiles in Healthy Non-Diabetic Participants: A Multicenter Prospective Study","author":"Shah","year":"2019","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.diabres.2020.108233_b0910","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.2337\/dc12-2127","article-title":"Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern?","volume":"36","author":"Monnier","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0915","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.2337\/diab.45.8.1044","article-title":"Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production","volume":"45","author":"Boden","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b0920","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.2337\/dc13-2088","article-title":"Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes","volume":"36","author":"Porcellati","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0925","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.diabres.2014.03.012","article-title":"Residual dysglycemia when at target HbA(1c) of 7% (53mmol\/mol) in persons with type 2 diabetes","volume":"104","author":"Monnier","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2020.108233_b0930","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2337\/dc06-1612","article-title":"The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes","volume":"30","author":"Monnier","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0935","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2337\/diacare.26.3.881","article-title":"Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c)","volume":"26","author":"Monnier","year":"2003","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2020.108233_b0940","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1089\/dia.2010.0239","article-title":"Postprandial and basal glucose in type 2 diabetes: assessment and respective impacts","volume":"13","author":"Monnier","year":"2011","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2020.108233_b0945","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2337\/dc16-1769","article-title":"Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes","volume":"40","author":"Monnier","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b0950","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/dia.2012.0333","article-title":"Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients","volume":"15","author":"Madhu","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2020.108233_b0955","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1932296817710478","article-title":"Diabetes and Prediabetes Classification Using Glycemic Variability Indices From Continuous Glucose Monitoring Data","volume":"12","author":"Acciaroli","year":"2018","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabres.2020.108233_b0960","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2213-8587(18)30037-8","article-title":"Precision nutrition for prevention and management of type 2 diabetes","volume":"6","author":"Wang","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2020.108233_b0965","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2015.11.001","article-title":"Personalized Nutrition by Prediction of Glycemic Responses","volume":"163","author":"Zeevi","year":"2015","journal-title":"Cell"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2020.108233_b0970","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1089\/dia.2008.0133","article-title":"The chemistry of commercial continuous glucose monitors","volume":"11","author":"McGarraugh","year":"2009","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2020.108233_b0975","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes","volume":"295","author":"Monnier","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2020.108233_b0980","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/dia.2018.0150","article-title":"Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes","volume":"20","author":"Wadwa","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2020.108233_b0985","first-page":"101118","article-title":"Calibration free continuous glucose monitoring (CGM) devices: Weighing up the benefits and limitations","author":"Monnier","year":"2019","journal-title":"Diabetes Metabol"},{"key":"10.1016\/j.diabres.2020.108233_b0990","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/dia.2016.0112","article-title":"Interstitial Fluid Glucose Is Not Just a Shifted-in-Time but a Distorted Mirror of Blood Glucose: Insight from an In Silico Study","volume":"18","author":"Cobelli","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2020.108233_b0995","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","article-title":"Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet (Lond, Engl)"},{"key":"10.1016\/j.diabres.2020.108233_b1000","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am J Physiol"},{"key":"10.1016\/j.diabres.2020.108233_b1005","first-page":"35","article-title":"Evaluation of insulin sensitivity in man","volume":"2","author":"Del Prato","year":"1986"},{"key":"10.1016\/j.diabres.2020.108233_b1010","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00125-011-2112-x","article-title":"Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study","volume":"54","author":"Ferrannini","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108233_b1015","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1056\/NEJM199312303292703","article-title":"Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians","volume":"329","author":"Lillioja","year":"1993","journal-title":"New Engl J Med"},{"key":"10.1016\/j.diabres.2020.108233_b1020","doi-asserted-by":"crossref","unstructured":"Bergman RN. Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes. 1989;38:1512\u201327.","DOI":"10.2337\/diabetes.38.12.1512"},{"key":"10.1016\/j.diabres.2020.108233_b1025","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00125-009-1464-y","article-title":"Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study","volume":"52","author":"Hanley","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108233_b1030","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0140-6736(92)92814-V","article-title":"Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study","volume":"340","author":"Martin","year":"1992","journal-title":"Lancet (Lond, Engl)"},{"key":"10.1016\/j.diabres.2020.108233_b1035","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0168-8227(99)00116-3","article-title":"Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures","volume":"47","author":"Gutt","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2020.108233_b1045","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2337\/diabetes.52.2.463","article-title":"Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study","volume":"52","author":"Hanley","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b1050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2337\/diacare.23.3.295","article-title":"Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity","volume":"23","author":"Stumvoll","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1055","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2337\/diacare.24.3.539","article-title":"A model-based method for assessing insulin sensitivity from the oral glucose tolerance test","volume":"24","author":"Mari","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1515\/CCLM.2007.015","article-title":"Surrogate markers of insulin resistance in assessing individuals with new categories \u201cprehypertension\u201d and \u201cprediabetes\u201d","volume":"45","author":"Kanauchi","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.diabres.2020.108233_b1065","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108233_b1070","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.2337\/dc12-0607","article-title":"Expansion of the homeostasis model assessment of beta-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2","volume":"36","author":"Hill","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/diacare.23.1.57","article-title":"Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity","volume":"23","author":"Bonora","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1080","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2337\/diacare.20.10.1562","article-title":"Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects","volume":"20","author":"Matsumoto","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1085","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2337\/diacare.20.7.1087","article-title":"The homeostasis model in the San Antonio Heart Study","volume":"20","author":"Haffner","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1090","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2337\/diacare.26.3.650","article-title":"Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans","volume":"26","author":"Hayashi","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1095","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.2337\/diabetes.53.7.1782","article-title":"Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study","volume":"53","author":"Bonora","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b1100","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.diabres.2020.108233_b1105","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.2337\/diabetes.54.7.1914","article-title":"Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model","volume":"54","author":"Chen","year":"2005","journal-title":"Diabetes"},{"issue":"Suppl 3","key":"10.1016\/j.diabres.2020.108233_b1110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-2362.32.s3.5.x","article-title":"The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes","volume":"32","author":"Bergman","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.diabres.2020.108233_b1115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","article-title":"The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes","volume":"46","author":"Kahn","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108233_b1120","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2337\/diab.41.12.1575","article-title":"The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents","volume":"41","author":"Gulli","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b1125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2337\/dc09-1115","article-title":"Insulin resistance, beta-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: the Insulin Resistance Atherosclerosis Study","volume":"33","author":"Lorenzo","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.tig.2017.01.010","article-title":"Genomics of Islet (Dys)function and Type 2 Diabetes","volume":"33","author":"Lawlor","year":"2017","journal-title":"Trends Genet: TIG"},{"key":"10.1016\/j.diabres.2020.108233_b1135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00125-003-1263-9","article-title":"Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study","volume":"47","author":"Gastaldelli","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108233_b1140","unstructured":"Del Prato S obotGSG. Insulin secretion and insulin action in individuals with different categories of glucose tolerance. The GENFIEV study. Diabetologia. 2006;49:375."},{"key":"10.1016\/j.diabres.2020.108233_b1145","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2337\/diacare.27.6.1439","article-title":"Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention","volume":"27","author":"Osei","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1150","doi-asserted-by":"crossref","unstructured":"DeFronzo RA, Ferrannini E, Simonson DC. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism: clinical and experimental. 1989;38:387\u201395.","DOI":"10.1016\/0026-0495(89)90129-7"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2020.108233_b1155","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.2337\/diabetes.51.2007.S109","article-title":"Phasic insulin release and metabolic regulation in type 2 diabetes","volume":"51","author":"Del Prato","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b1160","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/BF02658507","article-title":"Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance","volume":"39","author":"Haffner","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108233_b1165","first-page":"1138","article-title":"A prospective analysis of the HOMA model. The Mexico City Diabetes Study","volume":"19","author":"Haffner","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b1170","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1464-5491.1990.tb01415.x","article-title":"Fasting serum insulin concentration and early insulin response as risk determinants for developing diabetes","volume":"7","author":"Lundgren","year":"1990","journal-title":"Diabetic Med: J British Diabetic Assoc"},{"key":"10.1016\/j.diabres.2020.108233_b1175","doi-asserted-by":"crossref","unstructured":"Ferrannini E, Mari A. beta-Cell function in type 2 diabetes. Metabolism: clinical and experimental. 2014;63:1217\u201327.","DOI":"10.1016\/j.metabol.2014.05.012"},{"key":"10.1016\/j.diabres.2020.108233_b1180","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1573399810666140214093600","article-title":"Assessment of pancreatic beta-cell function: review of methods and clinical applications","volume":"10","author":"Cersosimo","year":"2014","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.diabres.2020.108233_b1185","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1007\/s00125-005-0004-7","article-title":"Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects","volume":"48","author":"Walker","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108233_b1190","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.2337\/dc07-0358","article-title":"Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study","volume":"30","author":"Song","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1195","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/diab.42.11.1663","article-title":"Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence a hyperbolic function","volume":"42","author":"Kahn","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b1200","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2337\/diabetes.52.4.903","article-title":"Glucose allostasis","volume":"52","author":"Stumvoll","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b1205","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1089\/met.2016.0137","article-title":"Prediabetes Exhibits Decreased Disposition Index Correlated with Deterioration of Glycemic Parameters in Nonobese Japanese Subjects: A Cross-Sectional Study from Medical Examination","volume":"15","author":"Takeda","year":"2017","journal-title":"Metabolic Syndrome Related Disorders"},{"key":"10.1016\/j.diabres.2020.108233_b1210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/dia.2015.0065","article-title":"beta-Cell Function and Insulin Sensitivity in Normal Glucose-Tolerant Subjects Stratified by 1-Hour Plasma Glucose Values","volume":"18","author":"Priya","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2020.108233_b1215","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2265.2008.03209.x","article-title":"Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia","volume":"69","author":"Qian","year":"2008","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.diabres.2020.108233_b1220","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-8587(13)70143-8","article-title":"Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome","volume":"2","author":"Roberts","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2020.108233_b1225","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2337\/dc15-2752","article-title":"alpha-Hydroxybutyric Acid Is a Selective Metabolite Biomarker of Impaired Glucose Tolerance","volume":"39","author":"Cobb","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1230","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2337\/dc17-1642","article-title":"Genetic Support for a Causal Role of Insulin Resistance on Circulating Branched-Chain Amino Acids and Inflammation","volume":"40","author":"Wang","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1235","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2337\/dc15-2251","article-title":"Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis","volume":"39","author":"Guasch-Ferre","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1240","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.2337\/db13-0570","article-title":"Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach","volume":"62","author":"Menni","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b1245","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm.2307","article-title":"Metabolite profiles and the risk of developing diabetes","volume":"17","author":"Wang","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.diabres.2020.108233_b1250","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2337\/dc15-2284","article-title":"Branched-Chain Amino Acids and Insulin Metabolism: The Insulin Resistance Atherosclerosis Study (IRAS)","volume":"39","author":"Lee","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1255","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00125-017-4222-6","article-title":"Genetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels","volume":"60","author":"Mahendran","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108233_b1260","doi-asserted-by":"crossref","first-page":"E1060","DOI":"10.1210\/jc.2012-4132","article-title":"Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics","volume":"98","author":"Xu","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2020.108233_b1265","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.2337\/dc13-0800","article-title":"Glycerol and fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in Finnish men","volume":"36","author":"Mahendran","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002409","article-title":"A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study","volume":"14","author":"Imamura","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.diabres.2020.108233_b1275","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1172\/JCI44442","article-title":"Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans","volume":"121","author":"Rhee","year":"2011","journal-title":"J Clin Investig"},{"key":"10.1016\/j.diabres.2020.108233_b1280","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2337\/db12-0495","article-title":"Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach","volume":"62","author":"Floegel","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b1285","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.2337\/dc18-0840","article-title":"Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial","volume":"41","author":"Razquin","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1290","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3945\/jn.108.103754","article-title":"Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women","volume":"139","author":"Adams","year":"2009","journal-title":"J Nutr"},{"key":"10.1016\/j.diabres.2020.108233_b1295","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/oby.2009.510","article-title":"Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity","volume":"18","author":"Mihalik","year":"2010","journal-title":"Obesity (Silver Spring, Md)"},{"key":"10.1016\/j.diabres.2020.108233_b1300","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2337\/dc16-0232","article-title":"Early Prediction of Developing Type 2 Diabetes by Plasma Acylcarnitines: A Population-Based Study","volume":"39","author":"Sun","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1305","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/msb.2012.43","article-title":"Novel biomarkers for pre-diabetes identified by metabolomics","volume":"8","author":"Wang-Sattler","year":"2012","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.diabres.2020.108233_b1310","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00125-017-4521-y","article-title":"Plasma metabolites associated with type 2 diabetes in a Swedish population: a case-control study nested in a prospective cohort","volume":"61","author":"Shi","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108233_b1315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013953","article-title":"Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting","volume":"5","author":"Suhre","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2020.108233_b1320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015234","article-title":"Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women","volume":"5","author":"Fiehn","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2020.108233_b1325","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1039\/C4MB00507D","article-title":"Investigating correlations in the altered metabolic profiles of obese and diabetic subjects in a South Indian Asian population using an NMR-based metabolomic approach","volume":"11","author":"Gogna","year":"2015","journal-title":"Mol BioSyst"},{"key":"10.1016\/j.diabres.2020.108233_b1330","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1373\/clinchem.2014.228965","article-title":"Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study","volume":"61","author":"Drogan","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.diabres.2020.108233_b1335","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cmet.2017.07.006","article-title":"Plasma Mannose Levels Are Associated with Incident Type 2 Diabetes and Cardiovascular Disease","volume":"26","author":"Mardinoglu","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.diabres.2020.108233_b1340","doi-asserted-by":"crossref","unstructured":"Carter TC, Rein D, Padberg I, Peter E, Rennefahrt U, David DE, et al. Validation of a metabolite panel for early diagnosis of type 2 diabetes. Metabolism: clinical and experimental. 2016;65:1399\u2013408.","DOI":"10.1016\/j.metabol.2016.06.007"},{"key":"10.1016\/j.diabres.2020.108233_b1345","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/1932296814553622","article-title":"A novel test for IGT utilizing metabolite markers of glucose tolerance","volume":"9","author":"Cobb","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabres.2020.108233_b1350","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1210\/jc.2015-4133","article-title":"Specific Metabolic Profiles and Their Relationship to Insulin Resistance in Recent-Onset Type 1 and Type 2 Diabetes","volume":"101","author":"Knebel","year":"2016","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.diabres.2020.108233_b1355","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s00125-009-1289-8","article-title":"Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study","volume":"52","author":"Ferrannini","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108233_b1360","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1210\/jc.2008-2625","article-title":"Clinical review: Realistic expectations and practical use of continuous glucose monitoring for the endocrinologist","volume":"94","author":"Hirsch","year":"2009","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.diabres.2020.108233_b1365","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.biochi.2010.12.003","article-title":"The glycation of albumin: structural and functional impacts","volume":"93","author":"Rondeau","year":"2011","journal-title":"Biochimie"},{"key":"10.1016\/j.diabres.2020.108233_b1370","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/clinchem\/38.7.1301","article-title":"Failure of common glycation assays to detect glycation by fructose","volume":"38","author":"Ahmed","year":"1992","journal-title":"Clin Chem"},{"key":"10.1016\/j.diabres.2020.108233_b1375","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S2213-8587(13)70199-2","article-title":"Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study","volume":"2","author":"Selvin","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2020.108233_b1380","article-title":"Association between Salivary Fructosamine, Plasma Glycated Hemoglobin, and Plasma Glucose Levels among Type II Diabetes Mellitus and Nondiabetic Individuals-A","author":"Kandavel","year":"2019","journal-title":"Cross-sectional Study European journal of dentistry"},{"key":"10.1016\/j.diabres.2020.108233_b1385","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0002-9629(15)40645-7","article-title":"Usefulness of fructosamine for monitoring outpatients with diabetes","volume":"318","author":"Austin","year":"1999","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.diabres.2020.108233_b1390","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.2337\/dc12-0787","article-title":"Alternative markers of hyperglycemia and risk of diabetes","volume":"35","author":"Juraschek","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1395","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4158\/EP.14.7.933","article-title":"Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists","volume":"14","author":"Garber","year":"2008","journal-title":"Endocrine Pract: Off J Am College Endocrinol Am Assoc Clin Endocrinologists"},{"key":"10.1016\/j.diabres.2020.108233_b1400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2013.04.003","article-title":"Evaluation of biological variation of glycated albumin (GA) and fructosamine in healthy subjects","volume":"423","author":"Montagnana","year":"2013","journal-title":"Clinica chimica acta; Int J Clin Chem"},{"key":"10.1016\/j.diabres.2020.108233_b1405","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1258\/acb.2009.009127","article-title":"Glycated albumin levels are higher relative to glycated haemoglobin levels in gastrectomized subjects","volume":"47","author":"Koga","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.diabres.2020.108233_b1410","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2337\/dc10-1945","article-title":"Nontraditional markers of glycemia: associations with microvascular conditions","volume":"34","author":"Selvin","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1415","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1507\/endocrj.K10E-138","article-title":"Clinical impact of glycated albumin as another glycemic control marker","volume":"57","author":"Koga","year":"2010","journal-title":"Endocr J"},{"key":"10.1016\/j.diabres.2020.108233_b1420","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.dsx.2018.08.007","article-title":"A comparative analysis of fructosamine with other risk factors for kidney dysfunction in diabetic patients with or without chronic kidney disease","volume":"13","author":"Neelofar","year":"2019","journal-title":"Diabetes Metabol Syndrome"},{"key":"10.1016\/j.diabres.2020.108233_b1425","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/1753-0407.12618","article-title":"Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study","volume":"10","author":"Jung","year":"2018","journal-title":"J Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b1430","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1758-5996-6-16","article-title":"Effect of a short-term exercise program on glycemic control measured by fructosamine test in type 2 diabetes patients","volume":"6","author":"Moura","year":"2014","journal-title":"Diabetol Metabol Syndrome"},{"key":"10.1016\/j.diabres.2020.108233_b1435","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1507\/endocrj.K07E-089","article-title":"Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes","volume":"55","author":"Yoshiuchi","year":"2008","journal-title":"Endocr J"},{"key":"10.1016\/j.diabres.2020.108233_b1440","doi-asserted-by":"crossref","unstructured":"Yogev Y, Hod M. Use of new technologies for monitoring and treating diabetes in pregnancy. Obstetrics and gynecology clinics of North America. 2007;34:241\u201353, viii.","DOI":"10.1016\/j.ogc.2007.03.005"},{"key":"10.1016\/j.diabres.2020.108233_b1445","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0002-9378(83)90443-X","article-title":"Biphasic changes in hemoglobin A1c concentrations during normal human pregnancy","volume":"147","author":"Phelps","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.diabres.2020.108233_b1450","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF02912884","article-title":"Paired values of serum fructosamine and blood glucose for the screening of gestational diabetes mellitus: A retrospective study of 165 Saudi pregnant women","volume":"22","author":"Khan","year":"2007","journal-title":"Indian J Clin Biochem: IJCB"},{"key":"10.1016\/j.diabres.2020.108233_b1455","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1097\/00029330-200611020-00003","article-title":"Value of fructosamine measurement in pregnant women with abnormal glucose tolerance","volume":"119","author":"Li","year":"2006","journal-title":"Chin Med J"},{"key":"10.1016\/j.diabres.2020.108233_b1460","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0002-9378(86)90743-X","article-title":"Serum fructosamine: a screening test for diabetes in pregnancy","volume":"154","author":"Roberts","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.diabres.2020.108233_b1465","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/clinchem\/34.2.309","article-title":"Serum fructosamine in diabetic pregnancy","volume":"34","author":"Frandsen","year":"1988","journal-title":"Clin Chem"},{"key":"10.1016\/j.diabres.2020.108233_b1470","first-page":"151","article-title":"Markers of Glycemic Control and Neonatal Morbidity in High-Risk Insulin-Resistant Pregnancies","volume":"33","author":"Cahill","year":"2016","journal-title":"Am J Perinatol"},{"issue":"10","key":"10.1016\/j.diabres.2020.108233_b1475","article-title":"Hivert MF. Mid-Pregnancy Fructosamine Measurement-Predictive Value for Gestational Diabetes and Association with Postpartum Glycemic Indices","author":"Gingras","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.diabres.2020.108233_b1480","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/14789450.2017.1352473","article-title":"Abundance matters: role of albumin in diabetes, a proteomics perspective","volume":"14","author":"Bhat","year":"2017","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.diabres.2020.108233_b1485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4239\/wjd.v10.i1.1","article-title":"Update on biomarkers of glycemic control","volume":"10","author":"Krhac","year":"2019","journal-title":"World J Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b1490","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s12020-016-1091-6","article-title":"Glycated albumin: from biochemistry and laboratory medicine to clinical practice","volume":"55","author":"Dozio","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.diabres.2020.108233_b1495","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10719-017-9789-0","article-title":"An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus","volume":"34","author":"Neelofar","year":"2017","journal-title":"Glycoconj J"},{"key":"10.1016\/j.diabres.2020.108233_b1500","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.diabres.2018.03.017","article-title":"Usefulness of glycated albumin as a biomarker for glucose control and prognostic factor in chronic kidney disease patients on dialysis (CKD-G5D)","volume":"140","author":"Dozio","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2020.108233_b1505","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4103\/1319-2442.109568","article-title":"Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence","volume":"24","author":"Sany","year":"2013","journal-title":"Saudi J Kidney Dis Transplant: Off Publ Saudi Center Organ Transplant, Saudi Arabia"},{"key":"10.1016\/j.diabres.2020.108233_b1510","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jdiacomp.2018.07.004","article-title":"The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges","volume":"32","author":"Gan","year":"2018","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.diabres.2020.108233_b1515","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.dsx.2017.12.013","article-title":"Challenges in diagnosing and monitoring diabetes in patients with chronic liver diseases","volume":"12","author":"Silva","year":"2018","journal-title":"Diabetes Metabol Syndrome"},{"key":"10.1016\/j.diabres.2020.108233_b1520","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrendo.2017.127","article-title":"Reversing the tide - diagnosis and prevention of T2DM in populations of African descent","volume":"14","author":"Utumatwishima","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.diabres.2020.108233_b1525","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cca.2018.05.044","article-title":"Associations of body mass index with glycated albumin and glycated albumin\/glycated hemoglobin A1c ratio in Chinese diabetic and non-diabetic populations","volume":"484","author":"He","year":"2018","journal-title":"Clinica chimica acta; Int J Clin Chem"},{"key":"10.1016\/j.diabres.2020.108233_b1530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089478","article-title":"The relationship between BMI and glycated albumin to glycated hemoglobin (GA\/A1c) ratio according to glucose tolerance status","volume":"9","author":"Huh","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2020.108233_b1535","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2013-000002","article-title":"Comparative associations of diabetes risk factors with five measures of hyperglycemia","volume":"2","author":"Poon","year":"2014","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.diabres.2020.108233_b1540","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/0004563215599178","article-title":"Committee on Diabetes Mellitus Indices of the Japan Society of Clinical Chemistry-recommended reference measurement procedure and reference materials for glycated albumin determination","volume":"53","author":"Takei","year":"2016","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.diabres.2020.108233_b1545","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1515\/cclm-2017-0179","article-title":"Definition of the upper reference limit of glycated albumin in blood donors from Italy","volume":"56","author":"Bellia","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.diabres.2020.108233_b1550","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1373\/clinchem.2017.285742","article-title":"Establishment of Community-Based Reference Intervals for Fructosamine, Glycated Albumin, and 1,5-Anhydroglucitol","volume":"64","author":"Selvin","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/j.diabres.2020.108233_b1555","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3164\/jcbn.17-81","article-title":"Early diagnosis of type 2 diabetes based on multiple biomarkers and non-invasive indices","volume":"62","author":"Umeno","year":"2018","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.diabres.2020.108233_b1560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2014.06.027","article-title":"Optimal glycated albumin cutoff value to diagnose diabetes in Korean adults: a retrospective study based on the oral glucose tolerance test","volume":"437","author":"Hwang","year":"2014","journal-title":"Clinica chimica acta; Int J Clin Chem"},{"key":"10.1016\/j.diabres.2020.108233_b1565","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijgo.2013.01.017","article-title":"Influence of insulin sensitivity and secretion on glycated albumin and hemoglobin A1c in pregnant women with gestational diabetes mellitus","volume":"121","author":"Pan","year":"2013","journal-title":"Int J Gynaecol Obstetr: Off Organ Int Federation Gynaecol Obstetr"},{"key":"10.1016\/j.diabres.2020.108233_b1570","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.4158\/EP14570.OR","article-title":"GLYCATED ALBUMIN AT 4 WEEKS CORRELATES WITH A1C LEVELS AT 12 WEEKS AND REFLECTS SHORT-TERM GLUCOSE FLUCTUATIONS","volume":"21","author":"Desouza","year":"2015","journal-title":"Endocrine Pract: Off J Am College Endocrinol Am Assoc Clin Endocrinologists"},{"key":"10.1016\/j.diabres.2020.108233_b1575","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s13340-016-0274-y","article-title":"Usefulness of glycated albumin in decisions regarding the discontinuation of a diabetes drug and factors associated with poor glycemic control following discontinuation in patients with type 2 diabetes mellitus","volume":"8","author":"Masumoto","year":"2017","journal-title":"Diabetol Int"},{"key":"10.1016\/j.diabres.2020.108233_b1580","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00011-017-1089-4","article-title":"Glycated albumin (GA) and inflammation: role of GA as a potential marker of inflammation","volume":"67","author":"Roohk","year":"2018","journal-title":"Inflammation Res: Off J Eur Histamine Res Soc [et al]"},{"key":"10.1016\/j.diabres.2020.108233_b1585","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00592-010-0242-0","article-title":"Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients","volume":"48","author":"Lee","year":"2011","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabres.2020.108233_b1590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046517","article-title":"New indices for predicting glycaemic variability","volume":"7","author":"Ogawa","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2020.108233_b1595","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1080\/01443615.2019.1584886","article-title":"Association between glycated haemoglobin, glycated albumin and fructosamine with neonatal birthweight and large-for-date status infants in gestational diabetes mellitus: a prospective cohort study","volume":"39","author":"Mendes","year":"2019","journal-title":"J Obstetr Gynaecol: J Inst Obstetr Gynaecol"},{"key":"10.1016\/j.diabres.2020.108233_b1600","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1080\/01443615.2017.1412409","article-title":"Beyond self-monitored plasma glucose and HbA1c: the role of non-traditional glycaemic markers in gestational diabetes mellitus","volume":"38","author":"Mendes","year":"2018","journal-title":"J Obstetr Gynaecol: J Inst Obstetr Gynaecol"},{"key":"10.1016\/j.diabres.2020.108233_b1605","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/1573399811666150701143112","article-title":"HbA1c, Fructosamine, and Glycated Albumin in the Detection of Dysglycaemic Conditions","volume":"12","author":"Ribeiro","year":"2016","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.diabres.2020.108233_b1610","doi-asserted-by":"crossref","first-page":"36088","DOI":"10.1074\/jbc.M801698200","article-title":"In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs","volume":"283","author":"Cassese","year":"2008","journal-title":"J Biolog Chem"},{"key":"10.1016\/j.diabres.2020.108233_b1615","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3389\/fphys.2017.00723","article-title":"N-acetylcysteine Counteracts Adipose Tissue Macrophage Infiltration and Insulin Resistance Elicited by Advanced Glycated Albumin in Healthy Rats","volume":"8","author":"da Silva","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.diabres.2020.108233_b1620","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2337\/db17-1362","article-title":"Genome-Wide Association Study of Serum Fructosamine and Glycated Albumin in Adults Without Diagnosed Diabetes: Results From the Atherosclerosis Risk in Communities Study","volume":"67","author":"Loomis","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b1625","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.atherosclerosis.2012.09.005","article-title":"Serum glycated albumin predicts the progression of carotid arterial atherosclerosis","volume":"225","author":"Song","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.diabres.2020.108233_b1630","first-page":"1485","article-title":"Advanced glycated albumin impairs HDL anti-inflammatory activity and primes macrophages for inflammatory response that reduces reverse cholesterol transport","volume":"1821","author":"Okuda","year":"2012","journal-title":"BBA"},{"key":"10.1016\/j.diabres.2020.108233_b1635","first-page":"3532","article-title":"New insights into deleterious impacts of in vivo glycation on albumin antioxidant activities","volume":"1830","author":"Baraka-Vidot","year":"2013","journal-title":"BBA"},{"key":"10.1016\/j.diabres.2020.108233_b1640","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3233\/JAD-130914","article-title":"Posttranslational nitro-glycative modifications of albumin in Alzheimer's disease: implications in cytotoxicity and amyloid-beta peptide aggregation","volume":"40","author":"Ramos-Fernandez","year":"2014","journal-title":"J Alzheimer's Dis: JAD"},{"key":"10.1016\/j.diabres.2020.108233_b1645","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1210\/jc.2017-00439","article-title":"Alternative Measures of Hyperglycemia and Risk of Alzheimer's Disease in the Community: The Hisayama Study","volume":"102","author":"Mukai","year":"2017","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.diabres.2020.108233_b1650","first-page":"E268","article-title":"Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body","volume":"263","author":"Yamanouchi","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.diabres.2020.108233_b1655","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2337\/dc11-1462","article-title":"Serum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction","volume":"35","author":"Kim","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1660","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2337\/diacare.27.8.1859","article-title":"Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay","volume":"27","author":"McGill","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1665","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1089\/dia.2014.0346","article-title":"1,5-anhydroglucitol is associated with early-phase insulin secretion in chinese patients with newly diagnosed type 2 diabetes mellitus","volume":"17","author":"Ma","year":"2015","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2020.108233_b1670","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/clinchem\/40.11.2013","article-title":"Fully enzymatic method for determining 1,5-anhydro-D-glucitol in serum","volume":"40","author":"Fukumura","year":"1994","journal-title":"Clin Chem"},{"key":"10.1016\/j.diabres.2020.108233_b1675","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cccn.2004.08.013","article-title":"Evaluation of an assay for serum 1,5-anhydroglucitol (GlycoMark) and determination of reference intervals on the Hitachi 917 analyzer","volume":"350","author":"Nowatzke","year":"2004","journal-title":"Clinica chimica acta; Int J Clin Chem"},{"key":"10.1016\/j.diabres.2020.108233_b1680","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cca.2011.01.007","article-title":"Comparison of two assays for serum 1,5-anhydroglucitol","volume":"412","author":"Selvin","year":"2011","journal-title":"Clinica chimica acta; Int J Clin Chem"},{"key":"10.1016\/j.diabres.2020.108233_b1685","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/14737159.8.1.9","article-title":"1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions","volume":"8","author":"Dungan","year":"2008","journal-title":"Expert Rev Mol Diagnostics"},{"key":"10.1016\/j.diabres.2020.108233_b1690","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.dib.2018.08.165","article-title":"Data for serum 1,5 anhydroglucitol concentration in different populations","volume":"20","author":"Welter","year":"2018","journal-title":"Data Brief"},{"key":"10.1016\/j.diabres.2020.108233_b1695","doi-asserted-by":"crossref","DOI":"10.1002\/gepi.22243","article-title":"Heritability analysis of nontraditional glycemic biomarkers in the Atherosclerosis Risk in Communities Study","author":"Loomis","year":"2019","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.diabres.2020.108233_b1700","doi-asserted-by":"crossref","first-page":"11968","DOI":"10.1038\/s41598-017-12210-z","article-title":"Serum 1,5-anhydroglucitol when used with fasting plasma glucose improves the efficiency of diabetes screening in a Chinese population","volume":"7","author":"Ying","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2020.108233_b1705","doi-asserted-by":"crossref","first-page":"690","DOI":"10.4103\/2230-8210.190559","article-title":"Relationship of glycemic control markers - 1,5 anhydroglucitol, fructosamine, and glycated hemoglobin among Asian Indians with different degrees of glucose intolerance","volume":"20","author":"Pramodkumar","year":"2016","journal-title":"Indian J Endocrinol Metabol"},{"key":"10.1016\/j.diabres.2020.108233_b1710","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1373\/clinchem.2014.229427","article-title":"Association of 1,5-anhydroglucitol with diabetes and microvascular conditions","volume":"60","author":"Selvin","year":"2014","journal-title":"Clin Chem"},{"issue":"Suppl 2","key":"10.1016\/j.diabres.2020.108233_b1715","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.2337\/dc11-s207","article-title":"Is hyperglycemia a cardiovascular risk factor?","volume":"34","author":"Pistrosch","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1720","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2337\/dc16-0840","article-title":"Association of a Biomarker of Glucose Peaks, 1,5-Anhydroglucitol With Subclinical Cardiovascular Disease","volume":"39","author":"Liang","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108233_b1725","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2337\/db15-0607","article-title":"Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality","volume":"65","author":"Selvin","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b1730","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/dom.13755","article-title":"Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial","volume":"21","author":"Selvin","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2020.108233_b1735","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12933-017-0636-1","article-title":"Low 1,5-anhydroglucitol levels are associated with long-term cardiac mortality in acute coronary syndrome patients with hemoglobin A1c levels less than 70","volume":"16","author":"Ouchi","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2020.108233_b1740","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0140-6736(96)90672-8","article-title":"Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control","volume":"347","author":"Yamanouchi","year":"1996","journal-title":"Lancet (Lond, Engl)"},{"key":"10.1016\/j.diabres.2020.108233_b1745","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1464-5491.2005.01656.x","article-title":"Comparison of metabolic effects of pioglitazone, metformin, and glimepiride over 1 year in Japanese patients with newly diagnosed Type 2 diabetes","volume":"22","author":"Yamanouchi","year":"2005","journal-title":"Diabetic Med: J British Diabetic Assoc"},{"key":"10.1016\/j.diabres.2020.108233_b1750","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/1753-0407.12116","article-title":"Effect of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, on measurement of serum 1,5-anhydroglucitol","volume":"6","author":"Balis","year":"2014","journal-title":"J Diabetes"},{"key":"10.1016\/j.diabres.2020.108233_b1755","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1373\/clinchem.2012.188367","article-title":"Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose","volume":"58","author":"Juraschek","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.diabres.2020.108233_b1760","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000485843","article-title":"Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring","volume":"47","author":"Divani","year":"2018","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.diabres.2020.108233_b1765","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1093\/ndt\/gfu006","article-title":"Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?","volume":"29","author":"Speeckaert","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"SI","key":"10.1016\/j.diabres.2020.108233_b1770","first-page":"S156","article-title":"The utility of one-hour plasma glucose during OGTT for diagnosing type 2 diabetes in the Botnia Studies","volume":"62","author":"Ahuja","year":"2019","journal-title":"Diabetologia"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822720304836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822720304836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:13:49Z","timestamp":1759173229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822720304836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":354,"alternative-id":["S0168822720304836"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2020.108233","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of methods for detecting glycemic disorders","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2020.108233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108233"}}